The international consensus classification of eosinophilic disorders and systemic mastocytosis.

Wang, Sa A; Orazi, Attilio; Gotlib, Jason; Reiter, Andreas; Tzankov, Alexandar; Hasserjian, Robert P; Arber, Daniel A; Tefferi, Ayalew

Wang, Sa A; Orazi, Attilio; Gotlib, Jason; Reiter, Andreas; Tzankov, Alexandar; Hasserjian, Robert P; Arber, Daniel A; Tefferi, Ayalew.

Affiliation

Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Orazi A; Department of Pathology, Texas Tech University Health Science Center, Lubbock, Texas, USA.
Gotlib J; Division of Hematology, Department of Medicine, Stanford University School of Medicine/Stanford Cancer Institute, California, USA.
Reiter A; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Tzankov A; Department of Pathology, Universitätsspital Basel, Basel, Switzerland.
Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Arber DA; Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Tefferi A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

Am J Hematol ; 98(8): 1286-1306, 2023 08.

Article de En | MEDLINE | ID: mdl-37283522

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémies / Syndrome hyperéosinophilique / Mastocytose généralisée / Syndromes myéloprolifératifs Type d'étude: Diagnostic_studies / Guideline / Prognostic_studies Limites: Humans Langue: En Journal: Am J Hematol Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google